PROSPECTS OF APPLICATION OF THE LATEST PLANT-VITAMIN COMPLEX FOR PREVENTION AND TREATMENT OF ESTROGEN-DEPENDENT DISORDERS IN GYNECOLOGY

  • Zaychenko G. V докт. мед. наук, проф., завідувачка кафедри фармакології, Національний медичний університет імені О. О. Богомольця, Україна
  • Karpenko N. O. канд. біол. наук, завідувачка лабораторії репродуктивної ендокринології ДУ «Інститут проблем ендокринної патології ім. В. Я. Данилевського НАМН України», (2006-2020 рр.), Україна
  • Ravshanov T. B. канд. мед. наук, ТОВ «Органосін ЛТД», Україна
Keywords: women's health, premenstrual syndrome, menopause, combined phytovitamin preparations.

Abstract

Possibilities and prospects of correcting women's health disorders associated with hypoestrogenic conditions of various etiologies or hormonal imbalances are considered. The causes of estrogen deficiency and features of complaints in women of different ages with an emphasis on peri- and menopause are systematized. An alternative to menopausal hormone therapy (MHT) with the use of phytovitamin preparations is considered. The relationship of hormonal metabolism with vitamin and mineral status, feasibility and benefits of complex phyto-, vitamin- and mineral preparations is shown. The therapeutic efficacy of medicinal plants that are part of the complex phytopreparation "Forevia Maxi" ("Organosyn LTD") in accordance with the symptoms of premenstrual syndrome (PMS): vasomotor (shortness of breath, hot flushes, night sweats, blood pressure fluctuations), genitals and atrophy of the vagina, itching, burning, cystalgia, urinary incontinence, dyspareunia) complications, memory and cognitive impairment, decreased sexuality, libido, sleep disorders, mood swings, anxiety, depression, aggravating psycho-emotional state, osteoporotic changes. Data from clinical trials of phytoextracts are shown, which demonstrate that the effect of the components of Forevia Maxi significantly exceeds the effect of placebo, and sometimes not less than with the use of MHT. The obvious benefits of this tool and as an adjunct to the basic therapy of PMS and hypoestrogenic conditions, characterized by ease of use, good safety profile, allows you to individualize the approach to patients, which is important in cases of medical contraindications for hormone therapy. Forevia Maxi is also the most appropriate for use with MHT, as an additional component of the correction of hypothalamic-pituitary disorders and saturation of the body with essential minerals and vitamins.

References

Зайченко Г. В., Сініцина О. С., Карпенко Н. О. та ін. Розлади жіночого здоров’я внаслідок вікового дефіциту естрогенів та їх корекція (огляд літератури). Журнал Національної академії медичних наук України. 2019. Т 25. № 2. С. 211-222.

Артымук Н. В., Марочко К. В., Марочко Т. Ю., Тачкова О. А. Современные представления о предменструальном синдроме. Обзор литературы. Мать и дитя в Кузбассе. 2021. Т. 84. №1. С. 32-38. doi: 10.24411/2686-7338-2021-10003.

Bäckström T., Andreen L., Birzniece V. et al. The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs. 2003. Vol. 17. № 5. С. 325 342. https://doi.org/10.2165/00023210-200317050-00003.

Наказ № 676 МОЗ України від 31.12.2004 р. «Про затвердження клінічних протоколів з акушерської та гінекологічної допомоги»

Schnatz P.F., Banever A.E., Greene J.F., O’Sullivan D.M. Menopausal symptoms in clinical population: a pilot study. Мenopause. 2005. Vol. 12. № 5. P. 623–629. DOI: 10.1097/01.GME.0000156347.54144.AC.

Stuenkel C. A. Managing menopausal vasomotor symptoms in older women. Maturitas. 2021. Vol. 143. P. 36-40. https://doi.org/10.1016/j.maturitas.2020.08.005

Schaedel Z. et al. Management of sleep disorders in the menopausal transition. Post Reproductive Health. 2021. Vol. 27. № 4. P. 209-214 https://doi.org/10.1177/20533691211039151

Freeman E.W., Sammel M.D., Lin H. et al. Duration of menopausal hot flushes and associated risk factors. Obstetrics and gynecology. 2011. Vol.117. № 5. P. 1095 1104. doi: 10.1097/AOG.0b013e318214f0de. PMID: 21508748; PMCID: PMC3085137.2011;117:1095–1104.

Sriram U. Applying a Women's Health Lens to Endocrine and Metabolic Disorders. Indian Journal of Endocrinology and Metabolism. 2021. Vol. 25. № 3. P. 171 -175. doi: 10.4103/2230-8210.328899

Shea A. K. et al. Guideline No. 422c: Menopause: Mood, Sleep, and Cognition. Journal of Obstetrics and Gynaecology Canada. 2021. P. 1316-1323.e1. https://doi.org/10.1016/j.jogc.2021.08.009

Siregar M. F. G. et al. Literature Review: Menopause and Sexual Disorders. Open Access Macedonian Journal of Medical Sciences. 2021. Vol. 9. № T3. P. 298-304. https://doi.org/10.3889/oamjms.2021.6345.

Reus T. L. et al. Revisiting the effects of menopause on the skin: functional changes, clinical studies, in vitro models and therapeutic alternatives. Mechanisms of ageing and development. 2020. Vol.185. P 111193. https://doi.org/10.1016/j.mad.2019.111193.

Maas A. H. E. M. et al. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. European Heart Journal. 2021.Vol. 42. № 10. P. 967-984. https://doi.org/10.1093/eurheartj/ehaa1044.

Views:

220

Downloads:

177

Published
2022-03-21
Citations
How to Cite
Zaychenko G. V, Karpenko N. O., & Ravshanov T. B. (2022). PROSPECTS OF APPLICATION OF THE LATEST PLANT-VITAMIN COMPLEX FOR PREVENTION AND TREATMENT OF ESTROGEN-DEPENDENT DISORDERS IN GYNECOLOGY. World Science, (3(75). https://doi.org/10.31435/rsglobal_ws/30042022/7800
Section
Medicine